B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease.
B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease.
复制标题
B7H1/CD80 相互作用增强 PD-1 依赖性 T 细胞凋亡并改善移植物抗宿主病
DOI:
10.4049/jimmunol.1402157
复制
发表时间:
2015-01-15
期刊:
影响因子:
--
通讯作者:
Zeng D
中科院分区:
文献类型:
--
作者:
Deng R;Cassady K;Li X;Yao S;Zhang M;Racine J;Lin J;Chen L;Zeng D
Interactions of B7H1 (PD-L1) with its two ligands, PD-1 and CD80, on T cells play a pivotal role in controlling T cell activation, proliferation, anergy, and apoptosis. However, the interactions between the two pathways remain unknown. Using an alloimmune response model of graft-versus-host disease (GVHD), we report here that: 1) Comparison of proliferation and apoptosis of wild-type (WT) and PD-1−/− CD4+ conventional T (Tcon) cells in WT and B7H1−/− recipients has revealed that B7H1/CD80 interaction per se augments T cell proliferation, and this interaction augments T cell apoptosis mediated by B7H1/PD-1 interaction. This observation was recapitulated in an in vitro mixed lymphocyte reaction assay. 2) Specific blockade of the B7H1/CD80 axis by anti-B7H1 mAb reduces WT-alloreactive Tcon cell proliferation, IL-2 production, expression of PD-1, and apoptosis, resulting in worsening GVHD. In contrast, specific blockade of B7H1/CD80 interaction reduces donor PD-1−/− Tcon cell proliferation without impact on apoptosis, resulting in ameliorating GVHD. 3) B7H1 fused to an immunoglobulin Fc domain (B7H1-Ig), when produced in vivo by hydrodynamic injection of B7H1-Ig plasmid, ameliorates GVHD by augmenting proliferation and apoptosis of WT- alloreactive Tcon cells. Conversely, B7H1-Ig treatment has no impact on apoptosis but augments PD-1−/− T cell proliferation and worsens GVHD. These results indicate that B7H1/CD80 interaction augments Tcon cell proliferation, IL-2 production, and expression of PD-1, which leads to increased apoptosis mediated by the B7H1/PD1 pathway. Additionally, by engaging both PD-1 and CD80, B7H1-Ig can be a powerful therapeutic reagent for down-regulating the T cell immune response.
登录
查看更多内容
影响因子:
32.4
作者:
Dong, HD;Zhu, GF;Chen, LP
通讯作者:
Chen, LP
DOI:
10.1038/nri3405
发表时间:
2013-04
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.4
作者:
Chemnitz, JM;Parry, RV;Riley, JL
通讯作者:
Riley, JL
影响因子:
17.1
作者:
Amarnath S;Mangus CW;Wang JC;Wei F;He A;Kapoor V;Foley JE;Massey PR;Felizardo TC;Riley JL;Levine BL;June CH;Medin JA;Fowler DH
通讯作者:
Fowler DH
影响因子:
56.9
作者:
SMITH, KA
通讯作者:
SMITH, KA